(London, UK) 20 August 2024. Predictive Health Intelligence’s flagship product, hepatoSIGHT, a case-finding search engine that enables clinicians to identify people potentially at risk for
Silent plight Our Medical Director Tim Jobson was recently featured in Pharma Times talking about why a new approach is needed for primary biliary cholangitis
Introduction Predictive Health Intelligence (PHI) was established in 2019. What started as an idea and developed into a successful grant application to the National Institute
Predictive Health Intelligence was recently part of a UK government trade delegation to the Arab Health Conference, which took place in Dubai at the end
The Missing Piece in Liver Disease Trials Our Medical Director Tim Jobson was recently featured in the Pharmaceutical Manufacturer talking about the missing piece in
We are excited to have been chosen by the Department for Business and Trade to be part of the UK government’s trade mission this key
Recently I have been interviewing patients who have been recalled for a review of their liver health using hepatoSIGHT. This is a simple tool that analyses blood tests going back over a number of years and allows a clinician to decide on a cohort of people who might benefit from a more detailed review.
Mark Wall is the Communications Lead for PHI and was part of the team representing the company at the recent EASL conference in Vienna. We
Dr Tim Jobson discusses the early detection of liver disease with Michael Betel of the Fatty Liver Alliance. Check out the entire interview here.
Our very own Dr Tim Jobson recently appeared on the podcast “Data Malarkey” to talk about Predictive Health Intelligence, the work we’re doing and hepatoSIGHT.